1. Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report. (May 2016) Authors: Warner, Margaret R.; Wolka, Anne M.; Noel, Rebecca A. Journal: Therapeutic innovation & regulatory science Issue: Volume 50:Number 3(2016:May) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Recommendations for benefit–risk assessment methodologies and visual representations§. Issue 3 (22nd January 2016) Authors: Hughes, Diana; Waddingham, Ed; Mt‐Isa, Shahrul; Goginsky, Alesia; Chan, Edmond; Downey, Gerald F.; Hallgreen, Christine E.; Hockley, Kimberley S.; Juhaeri, Juhaeri; Lieftucht, Alfons; Metcalf, Marilyn A.; Noel, Rebecca A.; Phillips, Lawrence D.; Ashby, Deborah; Micaleff, Alain Journal: Pharmacoepidemiology and drug safety Issue: Volume 25:Issue 3(2016) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. What is clearance worth? Patients' stated risk tolerance for psoriasis treatments. (17th November 2017) Authors: Fairchild, Angelyn O.; Reed, Shelby D.; Johnson, F. Reed; Anglin, Greg; Wolka, Anne M.; Noel, Rebecca A. Journal: Journal of dermatological treatment Issue: Volume 28:Number 8(2017) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗